Detalhe da pesquisa
1.
The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale).
BMC Cancer
; 18(1): 552, 2018 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29747595
2.
Herbal-drug interaction induced rhabdomyolysis in a liposarcoma patient receiving trabectedin.
BMC Complement Altern Med
; 13: 199, 2013 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-23899130
3.
The Interaction between Reactive Peritoneal Mesothelial Cells and Tumor Cells via Extracellular Vesicles Facilitates Colorectal Cancer Dissemination.
Cancers (Basel)
; 13(10)2021 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34065529
4.
Examining the Relationship between Circulating CD4- CD8- Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy-Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma.
Cells
; 10(2)2021 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33669266
5.
Electrochemotherapy as a Trigger to Overcome Primary Resistance to Anti-PD-1 Treatment: A Case Report of Melanoma of the Scalp.
Front Oncol
; 11: 742666, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34604086
6.
Remote mentoring in laparotomic and laparoscopic cancer surgery during Covid-19 pandemic: an experimental setup based on mixed reality.
Med Educ Online
; 26(1): 1996923, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34713779
7.
Cemiplimab in an Elderly Frail Population of Patients With Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Center Real-Life Experience From Italy.
Front Oncol
; 11: 686308, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34820323
8.
Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case Report.
Front Oncol
; 10: 1073, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32733801
9.
Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors.
Pigment Cell Melanoma Res
; 29(6): 679-687, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27540956
10.
MicroRNA expression in BRAF-mutated and wild-type metastatic melanoma and its correlation with response duration to BRAF inhibitors.
Expert Opin Ther Targets
; 19(8): 1027-35, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26156293